REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
R$ 62.27
0.00%
(0.00) 1D
10-р сарын 9, 15:15:24 (GMT-3) · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN34...
Mkt. cap
78.54 тэрбум
Avg. vol.
910.00
Volume
0.00
52-wk high
R$ 73.13
52-wk low
R$ 49.91
Shares outstanding
101.14 сая
No. of employees
15 мян
Mkt. cap
78.54 тэрбум
Avg. vol.
910.00
Volume
0.00
52-wk high
R$ 73.13
52-wk low
R$ 49.91
Shares outstanding
101.14 сая
No. of employees
15 мян
News stories
From web sources and news partners
Yahoo Finance
·
2 цагийн өмнө
Regeneron reports 84-week Phase III data for Pasatru in adult FOP
The Globe and Mail
·
2 цагийн өмнө
Citi Keeps Their Hold Rating on Regeneron (REGN)
ad-hoc-news.de
·
3 цагийн өмнө
Regeneron reports Pasatru data and Citi holds Regeneron stock
ad-hoc-news.de
·
4 цагийн өмнө
Sanofi expanded Regeneron alliance: Sanofi stock gains 1.34 percent
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Employees15.3 мян
Founded1988
HeadquartersTarrytown, Нью-Йорк Муж Улс, Америкийн Нэгдсэн Улс
Sector-
Websiteregeneron.com